#FORMAT=WebAnno TSV 3.2
#T_SP=webanno.custom.Referent|entity|infstat
#T_RL=webanno.custom.Coref|type|BT_webanno.custom.Referent


#Text=4. Discussion
1-1	0-2	4.	_	_	_	_
1-2	3-13	Discussion	abstract	new	_	_

#Text=Renewed focus on functional and quality of life outcomes after surgery for DCM in adults has come from rigorous scrutiny of the results of several large-scale studies in the last decade .
2-1	14-21	Renewed	abstract[2]	new[2]	coref	4-30[32_2]
2-2	22-27	focus	abstract[2]	new[2]	_	_
2-3	28-30	on	abstract[2]	new[2]	_	_
2-4	31-41	functional	abstract[2]	new[2]	_	_
2-5	42-45	and	abstract[2]	new[2]	_	_
2-6	46-53	quality	abstract[2]|abstract	new[2]|new	coref	3-35
2-7	54-56	of	_	_	_	_
2-8	57-61	life	abstract|abstract[5]	new|new[5]	coref|coref|coref|coref	2-22[10_5]|3-37|2-22[10_5]|3-37
2-9	62-70	outcomes	abstract[5]	new[5]	_	_
2-10	71-76	after	_	_	_	_
2-11	77-84	surgery	event[6]	new[6]	coref	3-8[0_6]
2-12	85-88	for	event[6]	new[6]	_	_
2-13	89-92	DCM	event[6]|abstract[7]	new[6]|new[7]	coref	5-15[0_7]
2-14	93-95	in	event[6]|abstract[7]	new[6]|new[7]	_	_
2-15	96-102	adults	event[6]|abstract[7]|person	new[6]|new[7]|new	coref	11-23[88_0]
2-16	103-106	has	_	_	_	_
2-17	107-111	come	_	_	_	_
2-18	112-116	from	_	_	_	_
2-19	117-125	rigorous	abstract[9]	new[9]	_	_
2-20	126-134	scrutiny	abstract[9]	new[9]	_	_
2-21	135-137	of	abstract[9]	new[9]	_	_
2-22	138-141	the	abstract[9]|abstract[10]	new[9]|giv[10]	coref	5-10[36_10]
2-23	142-149	results	abstract[9]|abstract[10]	new[9]|giv[10]	_	_
2-24	150-152	of	abstract[9]|abstract[10]	new[9]|giv[10]	_	_
2-25	153-160	several	abstract[9]|abstract[10]|abstract[11]	new[9]|giv[10]|new[11]	coref	4-33[33_11]
2-26	161-172	large-scale	abstract[9]|abstract[10]|abstract[11]	new[9]|giv[10]|new[11]	_	_
2-27	173-180	studies	abstract[9]|abstract[10]|abstract[11]	new[9]|giv[10]|new[11]	_	_
2-28	181-183	in	abstract[9]|abstract[10]|abstract[11]	new[9]|giv[10]|new[11]	_	_
2-29	184-187	the	abstract[9]|abstract[10]|abstract[11]|time[12]	new[9]|giv[10]|new[11]|new[12]	_	_
2-30	188-192	last	abstract[9]|abstract[10]|abstract[11]|time[12]	new[9]|giv[10]|new[11]|new[12]	_	_
2-31	193-199	decade	abstract[9]|abstract[10]|abstract[11]|time[12]	new[9]|giv[10]|new[11]|new[12]	_	_
2-32	200-201	.	_	_	_	_

#Text=The traditional doctrine of the use of surgery to ‘ arrest clinical progression ’ has been replaced with a more modern approach with decompressive surgery used as a means to provide both functional and quality of life improvement .
3-1	202-205	The	abstract[13]	new[13]	_	_
3-2	206-217	traditional	abstract[13]	new[13]	_	_
3-3	218-226	doctrine	abstract[13]	new[13]	_	_
3-4	227-229	of	abstract[13]	new[13]	_	_
3-5	230-233	the	abstract[13]|abstract[14]	new[13]|new[14]	_	_
3-6	234-237	use	abstract[13]|abstract[14]	new[13]|new[14]	_	_
3-7	238-240	of	abstract[13]|abstract[14]	new[13]|new[14]	_	_
3-8	241-248	surgery	abstract[13]|abstract[14]|event	new[13]|new[14]|giv	coref	3-24[19_0]
3-9	249-251	to	abstract[13]|abstract[14]	new[13]|new[14]	_	_
3-10	252-253	‘	abstract[13]|abstract[14]	new[13]|new[14]	_	_
3-11	254-260	arrest	abstract[13]|abstract[14]|event	new[13]|new[14]|new	_	_
3-12	261-269	clinical	abstract[13]|abstract[14]|abstract[17]	new[13]|new[14]|new[17]	_	_
3-13	270-281	progression	abstract[13]|abstract[14]|abstract[17]	new[13]|new[14]|new[17]	_	_
3-14	282-283	’	abstract[13]|abstract[14]|abstract[17]	new[13]|new[14]|new[17]	_	_
3-15	284-287	has	_	_	_	_
3-16	288-292	been	_	_	_	_
3-17	293-301	replaced	_	_	_	_
3-18	302-306	with	_	_	_	_
3-19	307-308	a	abstract[18]	new[18]	_	_
3-20	309-313	more	abstract[18]	new[18]	_	_
3-21	314-320	modern	abstract[18]	new[18]	_	_
3-22	321-329	approach	abstract[18]	new[18]	_	_
3-23	330-334	with	abstract[18]	new[18]	_	_
3-24	335-348	decompressive	abstract[18]|event[19]	new[18]|giv[19]	coref	5-13[37_19]
3-25	349-356	surgery	abstract[18]|event[19]	new[18]|giv[19]	_	_
3-26	357-361	used	_	_	_	_
3-27	362-364	as	_	_	_	_
3-28	365-366	a	_	_	_	_
3-29	367-372	means	_	_	_	_
3-30	373-375	to	_	_	_	_
3-31	376-383	provide	_	_	_	_
3-32	384-388	both	_	_	_	_
3-33	389-399	functional	_	_	_	_
3-34	400-403	and	_	_	_	_
3-35	404-411	quality	abstract	giv	coref	4-4[24_0]
3-36	412-414	of	_	_	_	_
3-37	415-419	life	abstract|abstract[22]	giv|new[22]	coref|coref|coref|coref	4-6|19-17[139_22]|4-6|19-17[139_22]
3-38	420-431	improvement	abstract[22]	new[22]	_	_
3-39	432-433	.	_	_	_	_

#Text=The assessment of quality of life metrics has become particularly important in the examination of patients with mild functional impairment ( or asymptomatic cord compression ) , and is the focus of a number of studies .
4-1	434-437	The	abstract[23]	new[23]	coref	21-26[156_23]
4-2	438-448	assessment	abstract[23]	new[23]	_	_
4-3	449-451	of	abstract[23]	new[23]	_	_
4-4	452-459	quality	abstract[23]|abstract[24]	new[23]|giv[24]	_	_
4-5	460-462	of	abstract[23]|abstract[24]	new[23]|giv[24]	_	_
4-6	463-467	life	abstract[23]|abstract[24]|abstract|abstract[26]	new[23]|giv[24]|giv|new[26]	coref|coref|coref|coref	11-37|24-4[186_26]|11-37|24-4[186_26]
4-7	468-475	metrics	abstract[23]|abstract[24]|abstract[26]	new[23]|giv[24]|new[26]	_	_
4-8	476-479	has	_	_	_	_
4-9	480-486	become	_	_	_	_
4-10	487-499	particularly	_	_	_	_
4-11	500-509	important	_	_	_	_
4-12	510-512	in	_	_	_	_
4-13	513-516	the	abstract[27]	new[27]	_	_
4-14	517-528	examination	abstract[27]	new[27]	_	_
4-15	529-531	of	abstract[27]	new[27]	_	_
4-16	532-540	patients	abstract[27]|person[28]	new[27]|new[28]	coref	7-4[0_28]
4-17	541-545	with	abstract[27]|person[28]	new[27]|new[28]	_	_
4-18	546-550	mild	abstract[27]|person[28]|abstract[29]	new[27]|new[28]|new[29]	coref	5-21[0_29]
4-19	551-561	functional	abstract[27]|person[28]|abstract[29]	new[27]|new[28]|new[29]	_	_
4-20	562-572	impairment	abstract[27]|person[28]|abstract[29]	new[27]|new[28]|new[29]	_	_
4-21	573-574	(	abstract[27]|person[28]	new[27]|new[28]	_	_
4-22	575-577	or	abstract[27]|person[28]	new[27]|new[28]	_	_
4-23	578-590	asymptomatic	abstract[27]|person[28]|abstract[31]	new[27]|new[28]|new[31]	_	_
4-24	591-595	cord	abstract[27]|person[28]|object|abstract[31]	new[27]|new[28]|new|new[31]	_	_
4-25	596-607	compression	abstract[27]|person[28]|abstract[31]	new[27]|new[28]|new[31]	_	_
4-26	608-609	)	abstract[27]|person[28]	new[27]|new[28]	_	_
4-27	610-611	,	_	_	_	_
4-28	612-615	and	_	_	_	_
4-29	616-618	is	_	_	_	_
4-30	619-622	the	abstract[32]	giv[32]	_	_
4-31	623-628	focus	abstract[32]	giv[32]	_	_
4-32	629-631	of	abstract[32]	giv[32]	_	_
4-33	632-633	a	abstract[32]|abstract[33]	giv[32]|giv[33]	coref	6-9[51_33]
4-34	634-640	number	abstract[32]|abstract[33]	giv[32]|giv[33]	_	_
4-35	641-643	of	abstract[32]|abstract[33]	giv[32]|giv[33]	_	_
4-36	644-651	studies	abstract[32]|abstract[33]	giv[32]|giv[33]	_	_
4-37	652-653	.	_	_	_	_

#Text=Careful evaluation has discovered a number of predictors of clinical outcomes from surgery for DCM , including baseline severity of impairment , duration of symptoms , presence of systemic or psychological co-morbidities , obesity , and of course age .
5-1	654-661	Careful	abstract[34]	new[34]	_	_
5-2	662-672	evaluation	abstract[34]	new[34]	_	_
5-3	673-676	has	_	_	_	_
5-4	677-687	discovered	_	_	_	_
5-5	688-689	a	abstract[35]	new[35]	_	_
5-6	690-696	number	abstract[35]	new[35]	_	_
5-7	697-699	of	abstract[35]	new[35]	_	_
5-8	700-710	predictors	abstract[35]	new[35]	_	_
5-9	711-713	of	abstract[35]	new[35]	_	_
5-10	714-722	clinical	abstract[35]|abstract[36]	new[35]|giv[36]	coref	6-13[52_36]
5-11	723-731	outcomes	abstract[35]|abstract[36]	new[35]|giv[36]	_	_
5-12	732-736	from	abstract[35]	new[35]	_	_
5-13	737-744	surgery	abstract[35]|event[37]	new[35]|giv[37]	coref	6-22[54_37]
5-14	745-748	for	abstract[35]|event[37]	new[35]|giv[37]	_	_
5-15	749-752	DCM	abstract[35]|event[37]|abstract	new[35]|giv[37]|giv	coref	6-24
5-16	753-754	,	_	_	_	_
5-17	755-764	including	_	_	_	_
5-18	765-773	baseline	abstract[39]	new[39]	_	_
5-19	774-782	severity	abstract[39]	new[39]	_	_
5-20	783-785	of	abstract[39]	new[39]	_	_
5-21	786-796	impairment	abstract[39]|abstract	new[39]|giv	coref	11-20[87_0]
5-22	797-798	,	abstract[39]	new[39]	_	_
5-23	799-807	duration	abstract[39]|time[41]	new[39]|new[41]	coref	7-8[57_41]
5-24	808-810	of	abstract[39]|time[41]	new[39]|new[41]	_	_
5-25	811-819	symptoms	abstract[39]|time[41]|abstract	new[39]|new[41]|new	coref	7-14
5-26	820-821	,	abstract[39]	new[39]	_	_
5-27	822-830	presence	abstract[39]|abstract[43]	new[39]|new[43]	_	_
5-28	831-833	of	abstract[39]|abstract[43]	new[39]|new[43]	_	_
5-29	834-842	systemic	abstract[39]|abstract[43]|abstract[44]|abstract[45]	new[39]|new[43]|new[44]|new[45]	coref|coref|coref|coref	7-21[0_44]|11-7[81_45]|7-21[0_44]|11-7[81_45]
5-30	843-845	or	abstract[39]|abstract[43]|abstract[44]|abstract[45]	new[39]|new[43]|new[44]|new[45]	_	_
5-31	846-859	psychological	abstract[39]|abstract[43]|abstract[44]|abstract[45]	new[39]|new[43]|new[44]|new[45]	_	_
5-32	860-874	co-morbidities	abstract[39]|abstract[43]|abstract[44]|abstract[45]	new[39]|new[43]|new[44]|new[45]	_	_
5-33	875-876	,	abstract[39]|abstract[43]|abstract[45]	new[39]|new[43]|new[45]	_	_
5-34	877-884	obesity	abstract[39]|abstract[43]|abstract[45]|abstract	new[39]|new[43]|new[45]|new	_	_
5-35	885-886	,	abstract[39]|abstract[43]|abstract[45]	new[39]|new[43]|new[45]	_	_
5-36	887-890	and	abstract[39]|abstract[43]|abstract[45]	new[39]|new[43]|new[45]	_	_
5-37	891-893	of	abstract[39]|abstract[43]|abstract[45]	new[39]|new[43]|new[45]	_	_
5-38	894-900	course	abstract[39]|abstract[43]|abstract[45]|abstract[47]	new[39]|new[43]|new[45]|new[47]	coref	6-20[0_47]
5-39	901-904	age	abstract[39]|abstract[43]|abstract[45]|abstract[47]	new[39]|new[43]|new[45]|new[47]	_	_
5-40	905-906	.	_	_	_	_

#Text=With simple univariate analysis of outcome measures , many studies have reported worse functional and QOL outcomes with increasing age after surgery for DCM .
6-1	907-911	With	_	_	_	_
6-2	912-918	simple	abstract[48]	new[48]	_	_
6-3	919-929	univariate	abstract[48]	new[48]	_	_
6-4	930-938	analysis	abstract[48]	new[48]	_	_
6-5	939-941	of	abstract[48]	new[48]	_	_
6-6	942-949	outcome	abstract[48]|abstract|abstract[50]	new[48]|new|new[50]	_	_
6-7	950-958	measures	abstract[48]|abstract[50]	new[48]|new[50]	_	_
6-8	959-960	,	_	_	_	_
6-9	961-965	many	abstract[51]	giv[51]	coref	20-13[147_51]
6-10	966-973	studies	abstract[51]	giv[51]	_	_
6-11	974-978	have	_	_	_	_
6-12	979-987	reported	_	_	_	_
6-13	988-993	worse	abstract[52]	giv[52]	coref	25-17[203_52]
6-14	994-1004	functional	abstract[52]	giv[52]	_	_
6-15	1005-1008	and	abstract[52]	giv[52]	_	_
6-16	1009-1012	QOL	abstract[52]	giv[52]	_	_
6-17	1013-1021	outcomes	abstract[52]	giv[52]	_	_
6-18	1022-1026	with	_	_	_	_
6-19	1027-1037	increasing	_	_	_	_
6-20	1038-1041	age	abstract	giv	coref	13-9[98_0]
6-21	1042-1047	after	_	_	_	_
6-22	1048-1055	surgery	event[54]	giv[54]	coref	17-13[0_54]
6-23	1056-1059	for	event[54]	giv[54]	_	_
6-24	1060-1063	DCM	event[54]|abstract	giv[54]|giv	coref	9-1
6-25	1064-1065	.	_	_	_	_

#Text=However , elderly patients often present with increased duration and worse severity of symptoms , with an increased incidence of co-morbidities .
7-1	1066-1073	However	_	_	_	_
7-2	1074-1075	,	_	_	_	_
7-3	1076-1083	elderly	_	_	_	_
7-4	1084-1092	patients	person	giv	coref	8-1[62_0]
7-5	1093-1098	often	_	_	_	_
7-6	1099-1106	present	_	_	_	_
7-7	1107-1111	with	_	_	_	_
7-8	1112-1121	increased	time[57]	giv[57]	_	_
7-9	1122-1130	duration	time[57]	giv[57]	_	_
7-10	1131-1134	and	_	_	_	_
7-11	1135-1140	worse	abstract[58]	new[58]	_	_
7-12	1141-1149	severity	abstract[58]	new[58]	_	_
7-13	1150-1152	of	abstract[58]	new[58]	_	_
7-14	1153-1161	symptoms	abstract[58]|abstract	new[58]|giv	coref	11-11[83_0]
7-15	1162-1163	,	_	_	_	_
7-16	1164-1168	with	_	_	_	_
7-17	1169-1171	an	abstract[60]	new[60]	_	_
7-18	1172-1181	increased	abstract[60]	new[60]	_	_
7-19	1182-1191	incidence	abstract[60]	new[60]	_	_
7-20	1192-1194	of	abstract[60]	new[60]	_	_
7-21	1195-1209	co-morbidities	abstract[60]|abstract	new[60]|giv	coref	11-7
7-22	1210-1211	.	_	_	_	_

#Text=Many elderly patients also present a high , sometimes unacceptable , surgical risk profile that makes decisions regarding surgical management less appropriate .
8-1	1212-1216	Many	person[62]	giv[62]	coref	14-3[103_62]
8-2	1217-1224	elderly	person[62]	giv[62]	_	_
8-3	1225-1233	patients	person[62]	giv[62]	_	_
8-4	1234-1238	also	_	_	_	_
8-5	1239-1246	present	_	_	_	_
8-6	1247-1248	a	abstract[64]	new[64]	_	_
8-7	1249-1253	high	abstract[64]	new[64]	_	_
8-8	1254-1255	,	abstract[64]	new[64]	_	_
8-9	1256-1265	sometimes	abstract[64]	new[64]	_	_
8-10	1266-1278	unacceptable	abstract[64]	new[64]	_	_
8-11	1279-1280	,	abstract[64]	new[64]	_	_
8-12	1281-1289	surgical	abstract[64]	new[64]	_	_
8-13	1290-1294	risk	abstract|abstract[64]	new|new[64]	_	_
8-14	1295-1302	profile	abstract[64]	new[64]	_	_
8-15	1303-1307	that	_	_	_	_
8-16	1308-1313	makes	_	_	_	_
8-17	1314-1323	decisions	abstract	new	_	_
8-18	1324-1333	regarding	_	_	_	_
8-19	1334-1342	surgical	event[66]	new[66]	_	_
8-20	1343-1353	management	event[66]	new[66]	_	_
8-21	1354-1358	less	_	_	_	_
8-22	1359-1370	appropriate	_	_	_	_
8-23	1371-1372	.	_	_	_	_

#Text=DCM is a disease that can cause a significant amount of potentially reversible or preventable neurological disability in the elderly population , and therefore concerted efforts should be made to improve decision-making strategies for this patient group .
9-1	1373-1376	DCM	abstract	giv	coref	9-3[68_0]
9-2	1377-1379	is	_	_	_	_
9-3	1380-1381	a	abstract[68]	giv[68]	coref	13-16[0_68]
9-4	1382-1389	disease	abstract[68]	giv[68]	_	_
9-5	1390-1394	that	_	_	_	_
9-6	1395-1398	can	_	_	_	_
9-7	1399-1404	cause	_	_	_	_
9-8	1405-1406	a	abstract[69]	new[69]	_	_
9-9	1407-1418	significant	abstract[69]	new[69]	_	_
9-10	1419-1425	amount	abstract[69]	new[69]	_	_
9-11	1426-1428	of	abstract[69]	new[69]	_	_
9-12	1429-1440	potentially	abstract[69]|abstract[70]	new[69]|new[70]	coref	22-4[0_70]
9-13	1441-1451	reversible	abstract[69]|abstract[70]	new[69]|new[70]	_	_
9-14	1452-1454	or	abstract[69]|abstract[70]	new[69]|new[70]	_	_
9-15	1455-1466	preventable	abstract[69]|abstract[70]	new[69]|new[70]	_	_
9-16	1467-1479	neurological	abstract[69]|abstract[70]	new[69]|new[70]	_	_
9-17	1480-1490	disability	abstract[69]|abstract[70]	new[69]|new[70]	_	_
9-18	1491-1493	in	abstract[69]|abstract[70]	new[69]|new[70]	_	_
9-19	1494-1497	the	abstract[69]|abstract[70]|person[71]	new[69]|new[70]|new[71]	_	_
9-20	1498-1505	elderly	abstract[69]|abstract[70]|person[71]	new[69]|new[70]|new[71]	_	_
9-21	1506-1516	population	abstract[69]|abstract[70]|person[71]	new[69]|new[70]|new[71]	_	_
9-22	1517-1518	,	_	_	_	_
9-23	1519-1522	and	_	_	_	_
9-24	1523-1532	therefore	event[72]	new[72]	_	_
9-25	1533-1542	concerted	event[72]	new[72]	_	_
9-26	1543-1550	efforts	event[72]	new[72]	_	_
9-27	1551-1557	should	_	_	_	_
9-28	1558-1560	be	_	_	_	_
9-29	1561-1565	made	_	_	_	_
9-30	1566-1568	to	_	_	_	_
9-31	1569-1576	improve	_	_	_	_
9-32	1577-1592	decision-making	_	_	_	_
9-33	1593-1603	strategies	abstract[73]	new[73]	_	_
9-34	1604-1607	for	abstract[73]	new[73]	_	_
9-35	1608-1612	this	abstract[73]|person[74]	new[73]|new[74]	coref	23-24[182_74]
9-36	1613-1620	patient	abstract[73]|person[74]	new[73]|new[74]	_	_
9-37	1621-1626	group	abstract[73]|person[74]	new[73]|new[74]	_	_
9-38	1627-1628	.	_	_	_	_

#Text=The results of the current study demonstrate a number of important conclusions , some of which have not been described in previous literature .
10-1	1629-1632	The	abstract[75]	new[75]	_	_
10-2	1633-1640	results	abstract[75]	new[75]	_	_
10-3	1641-1643	of	abstract[75]	new[75]	_	_
10-4	1644-1647	the	abstract[75]|abstract[76]	new[75]|new[76]	coref	18-8[133_76]
10-5	1648-1655	current	abstract[75]|abstract[76]	new[75]|new[76]	_	_
10-6	1656-1661	study	abstract[75]|abstract[76]	new[75]|new[76]	_	_
10-7	1662-1673	demonstrate	_	_	_	_
10-8	1674-1675	a	abstract[77]	new[77]	ana	10-14[0_77]
10-9	1676-1682	number	abstract[77]	new[77]	_	_
10-10	1683-1685	of	abstract[77]	new[77]	_	_
10-11	1686-1695	important	abstract[77]	new[77]	_	_
10-12	1696-1707	conclusions	abstract[77]	new[77]	_	_
10-13	1708-1709	,	_	_	_	_
10-14	1710-1714	some	abstract	giv	_	_
10-15	1715-1717	of	_	_	_	_
10-16	1718-1723	which	_	_	_	_
10-17	1724-1728	have	_	_	_	_
10-18	1729-1732	not	_	_	_	_
10-19	1733-1737	been	_	_	_	_
10-20	1738-1747	described	_	_	_	_
10-21	1748-1750	in	_	_	_	_
10-22	1751-1759	previous	abstract[79]	new[79]	_	_
10-23	1760-1770	literature	abstract[79]	new[79]	_	_
10-24	1771-1772	.	_	_	_	_

#Text=Firstly , even when matched for co-morbidities , duration of symptoms , sex , smoking status and severity of functional impairment , younger adults report significantly worse effects on their baseline physical and mental quality of life scores compared to the older aged cohort .
11-1	1773-1780	Firstly	_	_	_	_
11-2	1781-1782	,	_	_	_	_
11-3	1783-1787	even	_	_	_	_
11-4	1788-1792	when	_	_	_	_
11-5	1793-1800	matched	_	_	_	_
11-6	1801-1804	for	_	_	_	_
11-7	1805-1819	co-morbidities	abstract|abstract[81]	giv|giv[81]	_	_
11-8	1820-1821	,	abstract[81]	giv[81]	_	_
11-9	1822-1830	duration	abstract[81]|time[82]	giv[81]|new[82]	_	_
11-10	1831-1833	of	abstract[81]|time[82]	giv[81]|new[82]	_	_
11-11	1834-1842	symptoms	abstract[81]|time[82]|abstract[83]	giv[81]|new[82]|giv[83]	_	_
11-12	1843-1844	,	abstract[81]|time[82]|abstract[83]	giv[81]|new[82]|giv[83]	_	_
11-13	1845-1848	sex	abstract[81]|time[82]|abstract[83]|abstract	giv[81]|new[82]|giv[83]|new	_	_
11-14	1849-1850	,	abstract[81]|time[82]|abstract[83]	giv[81]|new[82]|giv[83]	_	_
11-15	1851-1858	smoking	abstract[81]|time[82]|abstract[83]	giv[81]|new[82]|giv[83]	_	_
11-16	1859-1865	status	abstract[81]|time[82]|abstract[83]|abstract	giv[81]|new[82]|giv[83]|new	_	_
11-17	1866-1869	and	abstract[81]|time[82]|abstract[83]	giv[81]|new[82]|giv[83]	_	_
11-18	1870-1878	severity	abstract[81]|time[82]|abstract[83]|abstract[86]	giv[81]|new[82]|giv[83]|new[86]	_	_
11-19	1879-1881	of	abstract[81]|time[82]|abstract[83]|abstract[86]	giv[81]|new[82]|giv[83]|new[86]	_	_
11-20	1882-1892	functional	abstract[81]|time[82]|abstract[83]|abstract[86]|abstract[87]	giv[81]|new[82]|giv[83]|new[86]|giv[87]	coref	16-6[0_87]
11-21	1893-1903	impairment	abstract[81]|time[82]|abstract[83]|abstract[86]|abstract[87]	giv[81]|new[82]|giv[83]|new[86]|giv[87]	_	_
11-22	1904-1905	,	_	_	_	_
11-23	1906-1913	younger	person[88]	giv[88]	ana	11-30[0_88]
11-24	1914-1920	adults	person[88]	giv[88]	_	_
11-25	1921-1927	report	_	_	_	_
11-26	1928-1941	significantly	abstract[89]	new[89]	coref	28-3[228_89]
11-27	1942-1947	worse	abstract[89]	new[89]	_	_
11-28	1948-1955	effects	abstract[89]	new[89]	_	_
11-29	1956-1958	on	abstract[89]	new[89]	_	_
11-30	1959-1964	their	abstract[89]|person|abstract[91]	new[89]|giv|new[91]	ana|coref|ana|coref	12-1[0_91]|21-41[160_0]|12-1[0_91]|21-41[160_0]
11-31	1965-1973	baseline	abstract[89]|abstract[91]	new[89]|new[91]	_	_
11-32	1974-1982	physical	abstract[89]|abstract[91]	new[89]|new[91]	_	_
11-33	1983-1986	and	abstract[89]|abstract[91]	new[89]|new[91]	_	_
11-34	1987-1993	mental	abstract[89]|abstract[91]	new[89]|new[91]	_	_
11-35	1994-2001	quality	abstract[89]|abstract[91]	new[89]|new[91]	_	_
11-36	2002-2004	of	abstract[89]|abstract[91]	new[89]|new[91]	_	_
11-37	2005-2009	life	abstract[89]|abstract[91]|abstract|abstract[93]	new[89]|new[91]|giv|new[93]	coref|coref|coref|coref	14-26|16-4[119_93]|14-26|16-4[119_93]
11-38	2010-2016	scores	abstract[89]|abstract[91]|abstract[93]	new[89]|new[91]|new[93]	_	_
11-39	2017-2025	compared	_	_	_	_
11-40	2026-2028	to	_	_	_	_
11-41	2029-2032	the	person[94]	new[94]	coref	17-2[123_94]
11-42	2033-2038	older	person[94]	new[94]	_	_
11-43	2039-2043	aged	person[94]	new[94]	_	_
11-44	2044-2050	cohort	person[94]	new[94]	_	_
11-45	2051-2052	.	_	_	_	_

#Text=This could be explained through 2 potential mechanisms .
12-1	2053-2057	This	abstract	giv	_	_
12-2	2058-2063	could	_	_	_	_
12-3	2064-2066	be	_	_	_	_
12-4	2067-2076	explained	_	_	_	_
12-5	2077-2084	through	_	_	_	_
12-6	2085-2086	2	abstract[96]	new[96]	coref	21-1[148_96]
12-7	2087-2096	potential	abstract[96]	new[96]	_	_
12-8	2097-2107	mechanisms	abstract[96]	new[96]	_	_
12-9	2108-2109	.	_	_	_	_

#Text=Firstly , as the younger cohort were of working age , the psychological impact of DCM may be greater if employment security is perceived to be threatened .
13-1	2110-2117	Firstly	_	_	_	_
13-2	2118-2119	,	_	_	_	_
13-3	2120-2122	as	_	_	_	_
13-4	2123-2126	the	person[97]	new[97]	coref	24-12[188_97]
13-5	2127-2134	younger	person[97]	new[97]	_	_
13-6	2135-2141	cohort	person[97]	new[97]	_	_
13-7	2142-2146	were	_	_	_	_
13-8	2147-2149	of	_	_	_	_
13-9	2150-2157	working	abstract[98]	giv[98]	coref	22-28[0_98]
13-10	2158-2161	age	abstract[98]	giv[98]	_	_
13-11	2162-2163	,	_	_	_	_
13-12	2164-2167	the	abstract[99]	new[99]	_	_
13-13	2168-2181	psychological	abstract[99]	new[99]	_	_
13-14	2182-2188	impact	abstract[99]	new[99]	_	_
13-15	2189-2191	of	abstract[99]	new[99]	_	_
13-16	2192-2195	DCM	abstract[99]|abstract	new[99]|giv	coref	14-16
13-17	2196-2199	may	_	_	_	_
13-18	2200-2202	be	_	_	_	_
13-19	2203-2210	greater	_	_	_	_
13-20	2211-2213	if	_	_	_	_
13-21	2214-2224	employment	abstract|abstract[102]	new|new[102]	_	_
13-22	2225-2233	security	abstract[102]	new[102]	_	_
13-23	2234-2236	is	_	_	_	_
13-24	2237-2246	perceived	_	_	_	_
13-25	2247-2249	to	_	_	_	_
13-26	2250-2252	be	_	_	_	_
13-27	2253-2263	threatened	_	_	_	_
13-28	2264-2265	.	_	_	_	_

#Text=Secondly , the elderly patients demonstrate psychological resilience or adaptations/support that mean the symptoms of DCM have a less pronounced effect on their quality of life .
14-1	2266-2274	Secondly	_	_	_	_
14-2	2275-2276	,	_	_	_	_
14-3	2277-2280	the	person[103]	giv[103]	ana	14-23[0_103]
14-4	2281-2288	elderly	person[103]	giv[103]	_	_
14-5	2289-2297	patients	person[103]	giv[103]	_	_
14-6	2298-2309	demonstrate	_	_	_	_
14-7	2310-2323	psychological	abstract[104]	new[104]	_	_
14-8	2324-2334	resilience	abstract[104]	new[104]	_	_
14-9	2335-2337	or	_	_	_	_
14-10	2338-2357	adaptations/support	abstract	new	_	_
14-11	2358-2362	that	_	_	_	_
14-12	2363-2367	mean	_	_	_	_
14-13	2368-2371	the	abstract[106]	new[106]	coref	21-18[153_106]
14-14	2372-2380	symptoms	abstract[106]	new[106]	_	_
14-15	2381-2383	of	abstract[106]	new[106]	_	_
14-16	2384-2387	DCM	abstract[106]|abstract	new[106]|giv	coref	25-25
14-17	2388-2392	have	_	_	_	_
14-18	2393-2394	a	abstract[108]	new[108]	_	_
14-19	2395-2399	less	abstract[108]	new[108]	_	_
14-20	2400-2410	pronounced	abstract[108]	new[108]	_	_
14-21	2411-2417	effect	abstract[108]	new[108]	_	_
14-22	2418-2420	on	abstract[108]	new[108]	_	_
14-23	2421-2426	their	abstract[108]|person|abstract[110]	new[108]|giv|new[110]	coref|coref	15-15[116_0]|15-15[116_0]
14-24	2427-2434	quality	abstract[108]|abstract[110]	new[108]|new[110]	_	_
14-25	2435-2437	of	abstract[108]|abstract[110]	new[108]|new[110]	_	_
14-26	2438-2442	life	abstract[108]|abstract[110]|abstract	new[108]|new[110]|giv	ana	15-1
14-27	2443-2444	.	_	_	_	_

#Text=This is an interesting concept , and is an important consideration for clinicians managing elderly DCM patients .
15-1	2445-2449	This	abstract	giv	coref	15-3[113_0]
15-2	2450-2452	is	_	_	_	_
15-3	2453-2455	an	abstract[113]	giv[113]	coref	25-17[0_113]
15-4	2456-2467	interesting	abstract[113]	giv[113]	_	_
15-5	2468-2475	concept	abstract[113]	giv[113]	_	_
15-6	2476-2477	,	abstract[113]	giv[113]	_	_
15-7	2478-2481	and	abstract[113]	giv[113]	_	_
15-8	2482-2484	is	abstract[113]	giv[113]	_	_
15-9	2485-2487	an	abstract[113]|abstract[114]	giv[113]|new[114]	_	_
15-10	2488-2497	important	abstract[113]|abstract[114]	giv[113]|new[114]	_	_
15-11	2498-2511	consideration	abstract[113]|abstract[114]	giv[113]|new[114]	_	_
15-12	2512-2515	for	abstract[113]|abstract[114]	giv[113]|new[114]	_	_
15-13	2516-2526	clinicians	abstract[113]|abstract[114]|person	giv[113]|new[114]|new	_	_
15-14	2527-2535	managing	_	_	_	_
15-15	2536-2543	elderly	person[116]	giv[116]	coref	16-1[117_116]
15-16	2544-2547	DCM	person[116]	giv[116]	_	_
15-17	2548-2556	patients	person[116]	giv[116]	_	_
15-18	2557-2558	.	_	_	_	_

#Text=All patients showed improved functional impairment scores after 2 years ( see Table 2 ) .
16-1	2559-2562	All	person[117]	giv[117]	coref	17-23[130_117]
16-2	2563-2571	patients	person[117]	giv[117]	_	_
16-3	2572-2578	showed	_	_	_	_
16-4	2579-2587	improved	abstract[119]	giv[119]	coref	19-5[136_119]
16-5	2588-2598	functional	abstract[119]	giv[119]	_	_
16-6	2599-2609	impairment	abstract|abstract[119]	giv|giv[119]	_	_
16-7	2610-2616	scores	abstract[119]	giv[119]	_	_
16-8	2617-2622	after	_	_	_	_
16-9	2623-2624	2	time[120]	new[120]	coref	19-8[137_120]
16-10	2625-2630	years	time[120]	new[120]	_	_
16-11	2631-2632	(	_	_	_	_
16-12	2633-2636	see	_	_	_	_
16-13	2637-2642	Table	abstract	new	_	_
16-14	2643-2644	2	quantity	new	_	_
16-15	2645-2646	)	_	_	_	_
16-16	2647-2648	.	_	_	_	_

#Text=Taking the older cohort in isolation , this is good evidence that surgery is an effective modality to produce functional improvements in elderly DCM patients .
17-1	2649-2655	Taking	_	_	_	_
17-2	2656-2659	the	person[123]	giv[123]	coref	19-33[143_123]
17-3	2660-2665	older	person[123]	giv[123]	_	_
17-4	2666-2672	cohort	person[123]	giv[123]	_	_
17-5	2673-2675	in	person[123]	giv[123]	_	_
17-6	2676-2685	isolation	person[123]|abstract	giv[123]|new	ana	17-8
17-7	2686-2687	,	_	_	_	_
17-8	2688-2692	this	abstract	giv	coref	17-10[126_0]
17-9	2693-2695	is	_	_	_	_
17-10	2696-2700	good	abstract[126]	giv[126]	coref	25-3[198_126]
17-11	2701-2709	evidence	abstract[126]	giv[126]	_	_
17-12	2710-2714	that	abstract[126]	giv[126]	_	_
17-13	2715-2722	surgery	abstract[126]|event	giv[126]|giv	coref	17-15[128_0]
17-14	2723-2725	is	abstract[126]	giv[126]	_	_
17-15	2726-2728	an	abstract[126]|event[128]	giv[126]|giv[128]	ana	18-1[0_128]
17-16	2729-2738	effective	abstract[126]|event[128]	giv[126]|giv[128]	_	_
17-17	2739-2747	modality	abstract[126]|event[128]	giv[126]|giv[128]	_	_
17-18	2748-2750	to	_	_	_	_
17-19	2751-2758	produce	_	_	_	_
17-20	2759-2769	functional	abstract[129]	new[129]	_	_
17-21	2770-2782	improvements	abstract[129]	new[129]	_	_
17-22	2783-2785	in	_	_	_	_
17-23	2786-2793	elderly	person[130]	giv[130]	coref	19-29[142_130]
17-24	2794-2797	DCM	person[130]	giv[130]	_	_
17-25	2798-2806	patients	person[130]	giv[130]	_	_
17-26	2807-2808	.	_	_	_	_

#Text=This is an important stand-alone conclusion from this study .
18-1	2809-2813	This	event	giv	coref	18-3[132_0]
18-2	2814-2816	is	_	_	_	_
18-3	2817-2819	an	event[132]	giv[132]	coref	19-22[0_132]
18-4	2820-2829	important	event[132]	giv[132]	_	_
18-5	2830-2841	stand-alone	event[132]	giv[132]	_	_
18-6	2842-2852	conclusion	event[132]	giv[132]	_	_
18-7	2853-2857	from	event[132]	giv[132]	_	_
18-8	2858-2862	this	event[132]|abstract[133]	giv[132]|giv[133]	coref	27-1[218_133]
18-9	2863-2868	study	event[132]|abstract[133]	giv[132]|giv[133]	_	_
18-10	2869-2870	.	_	_	_	_

#Text=When the change from baseline scores at 2 years is calculated , it becomes evident that the functional improvement seen after surgery is of a greater magnitude in younger patients compared to the older cohort .
19-1	2871-2875	When	_	_	_	_
19-2	2876-2879	the	abstract[134]	new[134]	ana	19-13[0_134]
19-3	2880-2886	change	abstract[134]	new[134]	_	_
19-4	2887-2891	from	abstract[134]	new[134]	_	_
19-5	2892-2900	baseline	abstract[134]|abstract|abstract[136]	new[134]|new|giv[136]	ana|coref|ana|coref	20-6[0_136]|23-10[177_0]|20-6[0_136]|23-10[177_0]
19-6	2901-2907	scores	abstract[134]|abstract[136]	new[134]|giv[136]	_	_
19-7	2908-2910	at	abstract[134]|abstract[136]	new[134]|giv[136]	_	_
19-8	2911-2912	2	abstract[134]|abstract[136]|time[137]	new[134]|giv[136]|giv[137]	_	_
19-9	2913-2918	years	abstract[134]|abstract[136]|time[137]	new[134]|giv[136]|giv[137]	_	_
19-10	2919-2921	is	_	_	_	_
19-11	2922-2932	calculated	_	_	_	_
19-12	2933-2934	,	_	_	_	_
19-13	2935-2937	it	abstract	giv	_	_
19-14	2938-2945	becomes	_	_	_	_
19-15	2946-2953	evident	_	_	_	_
19-16	2954-2958	that	_	_	_	_
19-17	2959-2962	the	abstract[139]	giv[139]	coref	24-7[187_139]
19-18	2963-2973	functional	abstract[139]	giv[139]	_	_
19-19	2974-2985	improvement	abstract[139]	giv[139]	_	_
19-20	2986-2990	seen	_	_	_	_
19-21	2991-2996	after	_	_	_	_
19-22	2997-3004	surgery	event	giv	coref	20-1[144_0]
19-23	3005-3007	is	_	_	_	_
19-24	3008-3010	of	_	_	_	_
19-25	3011-3012	a	abstract[141]	new[141]	coref	22-23[0_141]
19-26	3013-3020	greater	abstract[141]	new[141]	_	_
19-27	3021-3030	magnitude	abstract[141]	new[141]	_	_
19-28	3031-3033	in	abstract[141]	new[141]	_	_
19-29	3034-3041	younger	abstract[141]|person[142]	new[141]|giv[142]	coref	21-11[0_142]
19-30	3042-3050	patients	abstract[141]|person[142]	new[141]|giv[142]	_	_
19-31	3051-3059	compared	_	_	_	_
19-32	3060-3062	to	_	_	_	_
19-33	3063-3066	the	person[143]	giv[143]	coref	24-26[192_143]
19-34	3067-3072	older	person[143]	giv[143]	_	_
19-35	3073-3079	cohort	person[143]	giv[143]	_	_
19-36	3080-3081	.	_	_	_	_

#Text=This conclusion is similar to those described from previous univariate analyses in prior studies .
20-1	3082-3086	This	event[144]	giv[144]	coref	22-14[164_144]
20-2	3087-3097	conclusion	event[144]	giv[144]	_	_
20-3	3098-3100	is	_	_	_	_
20-4	3101-3108	similar	_	_	_	_
20-5	3109-3111	to	_	_	_	_
20-6	3112-3117	those	abstract	giv	coref	23-20[181_0]
20-7	3118-3127	described	_	_	_	_
20-8	3128-3132	from	_	_	_	_
20-9	3133-3141	previous	abstract[146]	new[146]	_	_
20-10	3142-3152	univariate	abstract[146]	new[146]	_	_
20-11	3153-3161	analyses	abstract[146]	new[146]	_	_
20-12	3162-3164	in	abstract[146]	new[146]	_	_
20-13	3165-3170	prior	abstract[146]|abstract[147]	new[146]|giv[147]	_	_
20-14	3171-3178	studies	abstract[146]|abstract[147]	new[146]|giv[147]	_	_
20-15	3179-3180	.	_	_	_	_

#Text=Suggested mechanisms for this discrepancy include the fact that elderly patients often present with increased duration of symptoms at diagnosis , often have difficulty accessing specialist assessment and imaging , and also have less neurological plasticity or reserve compared to younger adults .
21-1	3181-3190	Suggested	abstract[148]	giv[148]	_	_
21-2	3191-3201	mechanisms	abstract[148]	giv[148]	_	_
21-3	3202-3205	for	abstract[148]	giv[148]	_	_
21-4	3206-3210	this	abstract[148]|abstract[149]	giv[148]|new[149]	_	_
21-5	3211-3222	discrepancy	abstract[148]|abstract[149]	giv[148]|new[149]	_	_
21-6	3223-3230	include	_	_	_	_
21-7	3231-3234	the	abstract[150]	new[150]	_	_
21-8	3235-3239	fact	abstract[150]	new[150]	_	_
21-9	3240-3244	that	abstract[150]	new[150]	_	_
21-10	3245-3252	elderly	abstract[150]	new[150]	_	_
21-11	3253-3261	patients	abstract[150]|person	new[150]|giv	coref	22-16[165_0]
21-12	3262-3267	often	abstract[150]	new[150]	_	_
21-13	3268-3275	present	abstract[150]	new[150]	_	_
21-14	3276-3280	with	_	_	_	_
21-15	3281-3290	increased	time[152]	new[152]	_	_
21-16	3291-3299	duration	time[152]	new[152]	_	_
21-17	3300-3302	of	time[152]	new[152]	_	_
21-18	3303-3311	symptoms	time[152]|abstract[153]	new[152]|giv[153]	_	_
21-19	3312-3314	at	time[152]|abstract[153]	new[152]|giv[153]	_	_
21-20	3315-3324	diagnosis	time[152]|abstract[153]|event	new[152]|giv[153]|new	_	_
21-21	3325-3326	,	_	_	_	_
21-22	3327-3332	often	_	_	_	_
21-23	3333-3337	have	_	_	_	_
21-24	3338-3348	difficulty	abstract	new	_	_
21-25	3349-3358	accessing	_	_	_	_
21-26	3359-3369	specialist	abstract[156]	giv[156]	coref	27-27[225_156]
21-27	3370-3380	assessment	abstract[156]	giv[156]	_	_
21-28	3381-3384	and	_	_	_	_
21-29	3385-3392	imaging	event	new	_	_
21-30	3393-3394	,	_	_	_	_
21-31	3395-3398	and	_	_	_	_
21-32	3399-3403	also	_	_	_	_
21-33	3404-3408	have	_	_	_	_
21-34	3409-3413	less	abstract[158]	new[158]	_	_
21-35	3414-3426	neurological	abstract[158]	new[158]	_	_
21-36	3427-3437	plasticity	abstract[158]	new[158]	_	_
21-37	3438-3440	or	_	_	_	_
21-38	3441-3448	reserve	abstract	new	_	_
21-39	3449-3457	compared	_	_	_	_
21-40	3458-3460	to	_	_	_	_
21-41	3461-3468	younger	person[160]	giv[160]	_	_
21-42	3469-3475	adults	person[160]	giv[160]	_	_
21-43	3476-3477	.	_	_	_	_

#Text=The level of disability as measured by the NDI was improved significantly by surgery for all patients , but the order of magnitude was similar for both age groups ( p = 0.094 ) .
22-1	3478-3481	The	abstract[161]	new[161]	_	_
22-2	3482-3487	level	abstract[161]	new[161]	_	_
22-3	3488-3490	of	abstract[161]	new[161]	_	_
22-4	3491-3501	disability	abstract[161]|abstract	new[161]|giv	_	_
22-5	3502-3504	as	_	_	_	_
22-6	3505-3513	measured	_	_	_	_
22-7	3514-3516	by	_	_	_	_
22-8	3517-3520	the	abstract[163]	new[163]	_	_
22-9	3521-3524	NDI	abstract[163]	new[163]	_	_
22-10	3525-3528	was	_	_	_	_
22-11	3529-3537	improved	_	_	_	_
22-12	3538-3551	significantly	_	_	_	_
22-13	3552-3554	by	_	_	_	_
22-14	3555-3562	surgery	event[164]	giv[164]	coref	25-6[0_164]
22-15	3563-3566	for	event[164]	giv[164]	_	_
22-16	3567-3570	all	event[164]|person[165]	giv[164]|giv[165]	coref	23-1[172_165]
22-17	3571-3579	patients	event[164]|person[165]	giv[164]|giv[165]	_	_
22-18	3580-3581	,	_	_	_	_
22-19	3582-3585	but	_	_	_	_
22-20	3586-3589	the	quantity[166]	new[166]	_	_
22-21	3590-3595	order	quantity[166]	new[166]	_	_
22-22	3596-3598	of	quantity[166]	new[166]	_	_
22-23	3599-3608	magnitude	quantity[166]|abstract	new[166]|giv	coref	26-28[214_0]
22-24	3609-3612	was	_	_	_	_
22-25	3613-3620	similar	_	_	_	_
22-26	3621-3624	for	_	_	_	_
22-27	3625-3629	both	abstract[169]	new[169]	_	_
22-28	3630-3633	age	abstract|abstract[169]	giv|new[169]	_	_
22-29	3634-3640	groups	abstract[169]	new[169]	_	_
22-30	3641-3642	(	_	_	_	_
22-31	3643-3644	p	quantity	new	coref	24-30
22-32	3645-3646	=	_	_	_	_
22-33	3647-3652	0.094	quantity	new	_	_
22-34	3653-3654	)	_	_	_	_
22-35	3655-3656	.	_	_	_	_

#Text=All patients demonstrated improved SF-36 PCS and MCS from baseline at the 2-year interval , with the exception of the MCS scores in the elderly group .
23-1	3657-3660	All	person[172]	giv[172]	coref	25-20[204_172]
23-2	3661-3669	patients	person[172]	giv[172]	_	_
23-3	3670-3682	demonstrated	_	_	_	_
23-4	3683-3691	improved	abstract[173]|organization[174]|abstract[175]	new[173]|new[174]|new[175]	coref|coref|coref|coref|coref|coref|coref|coref|coref	24-1[183_174]|24-1[184_175]|28-14[0_173]|24-1[183_174]|24-1[184_175]|28-14[0_173]|24-1[183_174]|24-1[184_175]|28-14[0_173]
23-5	3692-3697	SF-36	abstract[173]|organization[174]|abstract[175]	new[173]|new[174]|new[175]	_	_
23-6	3698-3701	PCS	abstract[173]|organization[174]|abstract[175]	new[173]|new[174]|new[175]	_	_
23-7	3702-3705	and	abstract[173]|abstract[175]	new[173]|new[175]	_	_
23-8	3706-3709	MCS	abstract[173]|abstract[175]|abstract[176]	new[173]|new[175]|new[176]	coref	23-21[0_176]
23-9	3710-3714	from	abstract[173]|abstract[175]|abstract[176]	new[173]|new[175]|new[176]	_	_
23-10	3715-3723	baseline	abstract[173]|abstract[175]|abstract[176]|abstract[177]	new[173]|new[175]|new[176]|giv[177]	coref	24-23[0_177]
23-11	3724-3726	at	abstract[173]|abstract[175]|abstract[176]|abstract[177]	new[173]|new[175]|new[176]|giv[177]	_	_
23-12	3727-3730	the	abstract[173]|abstract[175]|abstract[176]|abstract[177]|time[178]	new[173]|new[175]|new[176]|giv[177]|new[178]	_	_
23-13	3731-3737	2-year	abstract[173]|abstract[175]|abstract[176]|abstract[177]|time[178]	new[173]|new[175]|new[176]|giv[177]|new[178]	_	_
23-14	3738-3746	interval	abstract[173]|abstract[175]|abstract[176]|abstract[177]|time[178]	new[173]|new[175]|new[176]|giv[177]|new[178]	_	_
23-15	3747-3748	,	abstract[173]	new[173]	_	_
23-16	3749-3753	with	abstract[173]	new[173]	_	_
23-17	3754-3757	the	abstract[173]|abstract[179]	new[173]|new[179]	_	_
23-18	3758-3767	exception	abstract[173]|abstract[179]	new[173]|new[179]	_	_
23-19	3768-3770	of	abstract[173]|abstract[179]	new[173]|new[179]	_	_
23-20	3771-3774	the	abstract[173]|abstract[179]|abstract[181]	new[173]|new[179]|giv[181]	_	_
23-21	3775-3778	MCS	abstract[173]|abstract[179]|abstract|abstract[181]	new[173]|new[179]|giv|giv[181]	coref	24-4
23-22	3779-3785	scores	abstract[173]|abstract[179]|abstract[181]	new[173]|new[179]|giv[181]	_	_
23-23	3786-3788	in	abstract[173]|abstract[179]|abstract[181]	new[173]|new[179]|giv[181]	_	_
23-24	3789-3792	the	abstract[173]|abstract[179]|abstract[181]|person[182]	new[173]|new[179]|giv[181]|giv[182]	_	_
23-25	3793-3800	elderly	abstract[173]|abstract[179]|abstract[181]|person[182]	new[173]|new[179]|giv[181]|giv[182]	_	_
23-26	3801-3806	group	abstract[173]|abstract[179]|abstract[181]|person[182]	new[173]|new[179]|giv[181]|giv[182]	_	_
23-27	3807-3808	.	_	_	_	_

#Text=Both PCS and MCS metrics echoed the functional improvement in that the younger cohort had a significantly greater degree of improvement from baseline compared to the older cohort ( p < 0.001 , p = 0.007 ) .
24-1	3809-3813	Both	organization[183]|abstract[184]	giv[183]|giv[184]	_	_
24-2	3814-3817	PCS	organization[183]|abstract[184]	giv[183]|giv[184]	_	_
24-3	3818-3821	and	abstract[184]	giv[184]	_	_
24-4	3822-3825	MCS	abstract[184]|abstract|abstract[186]	giv[184]|giv|giv[186]	_	_
24-5	3826-3833	metrics	abstract[184]|abstract[186]	giv[184]|giv[186]	_	_
24-6	3834-3840	echoed	_	_	_	_
24-7	3841-3844	the	abstract[187]	giv[187]	coref	24-21[190_187]
24-8	3845-3855	functional	abstract[187]	giv[187]	_	_
24-9	3856-3867	improvement	abstract[187]	giv[187]	_	_
24-10	3868-3870	in	_	_	_	_
24-11	3871-3875	that	_	_	_	_
24-12	3876-3879	the	person[188]	giv[188]	_	_
24-13	3880-3887	younger	person[188]	giv[188]	_	_
24-14	3888-3894	cohort	person[188]	giv[188]	_	_
24-15	3895-3898	had	_	_	_	_
24-16	3899-3900	a	abstract[189]	new[189]	_	_
24-17	3901-3914	significantly	abstract[189]	new[189]	_	_
24-18	3915-3922	greater	abstract[189]	new[189]	_	_
24-19	3923-3929	degree	abstract[189]	new[189]	_	_
24-20	3930-3932	of	abstract[189]	new[189]	_	_
24-21	3933-3944	improvement	abstract[189]|abstract[190]	new[189]|giv[190]	coref	26-22[213_190]
24-22	3945-3949	from	abstract[189]|abstract[190]	new[189]|giv[190]	_	_
24-23	3950-3958	baseline	abstract[189]|abstract[190]|abstract	new[189]|giv[190]|giv	ana	25-1
24-24	3959-3967	compared	_	_	_	_
24-25	3968-3970	to	_	_	_	_
24-26	3971-3974	the	person[192]	giv[192]	_	_
24-27	3975-3980	older	person[192]	giv[192]	_	_
24-28	3981-3987	cohort	person[192]	giv[192]	_	_
24-29	3988-3989	(	_	_	_	_
24-30	3990-3991	p	quantity	giv	coref	24-34
24-31	3992-3993	<	_	_	_	_
24-32	3994-3999	0.001	quantity	new	_	_
24-33	4000-4001	,	_	_	_	_
24-34	4002-4003	p	quantity	giv	_	_
24-35	4004-4005	=	_	_	_	_
24-36	4006-4011	0.007	quantity	new	_	_
24-37	4012-4013	)	_	_	_	_
24-38	4014-4015	.	_	_	_	_

#Text=This provides good evidence that surgery leads to increased physical and mental perception of quality of life outcomes in all patients undergoing surgery for DCM .
25-1	4016-4020	This	abstract	giv	_	_
25-2	4021-4029	provides	_	_	_	_
25-3	4030-4034	good	abstract[198]	giv[198]	_	_
25-4	4035-4043	evidence	abstract[198]	giv[198]	_	_
25-5	4044-4048	that	_	_	_	_
25-6	4049-4056	surgery	event	giv	coref	25-23
25-7	4057-4062	leads	_	_	_	_
25-8	4063-4065	to	_	_	_	_
25-9	4066-4075	increased	abstract[200]	new[200]	_	_
25-10	4076-4084	physical	abstract[200]	new[200]	_	_
25-11	4085-4088	and	abstract[200]	new[200]	_	_
25-12	4089-4095	mental	abstract[200]	new[200]	_	_
25-13	4096-4106	perception	abstract[200]	new[200]	_	_
25-14	4107-4109	of	abstract[200]	new[200]	_	_
25-15	4110-4117	quality	abstract[200]|abstract[201]	new[200]|new[201]	_	_
25-16	4118-4120	of	abstract[200]|abstract[201]	new[200]|new[201]	_	_
25-17	4121-4125	life	abstract[200]|abstract[201]|abstract|abstract[203]	new[200]|new[201]|giv|giv[203]	coref|coref	26-12|26-12
25-18	4126-4134	outcomes	abstract[200]|abstract[201]|abstract[203]	new[200]|new[201]|giv[203]	_	_
25-19	4135-4137	in	abstract[200]|abstract[201]|abstract[203]	new[200]|new[201]|giv[203]	_	_
25-20	4138-4141	all	abstract[200]|abstract[201]|abstract[203]|person[204]	new[200]|new[201]|giv[203]|giv[204]	_	_
25-21	4142-4150	patients	abstract[200]|abstract[201]|abstract[203]|person[204]	new[200]|new[201]|giv[203]|giv[204]	_	_
25-22	4151-4161	undergoing	_	_	_	_
25-23	4162-4169	surgery	event	giv	_	_
25-24	4170-4173	for	_	_	_	_
25-25	4174-4177	DCM	abstract	giv	coref	27-35
25-26	4178-4179	.	_	_	_	_

#Text=It appears that older patients ’ mental perception of quality of life remains stable throughout the treatment period , despite having a worse functional improvement , and less magnitude of quality of life improvement overall .
26-1	4180-4182	It	_	_	_	_
26-2	4183-4190	appears	_	_	_	_
26-3	4191-4195	that	_	_	_	_
26-4	4196-4201	older	person[207]|abstract[208]	new[207]|new[208]	coref|coref|coref|coref	27-32[226_207]|28-6[230_208]|27-32[226_207]|28-6[230_208]
26-5	4202-4210	patients	person[207]|abstract[208]	new[207]|new[208]	_	_
26-6	4211-4212	’	person[207]|abstract[208]	new[207]|new[208]	_	_
26-7	4213-4219	mental	abstract[208]	new[208]	_	_
26-8	4220-4230	perception	abstract[208]	new[208]	_	_
26-9	4231-4233	of	abstract[208]	new[208]	_	_
26-10	4234-4241	quality	abstract[208]|abstract[209]	new[208]|new[209]	_	_
26-11	4242-4244	of	abstract[208]|abstract[209]	new[208]|new[209]	_	_
26-12	4245-4249	life	abstract[208]|abstract[209]|time	new[208]|new[209]|giv	coref	26-16[212_0]
26-13	4250-4257	remains	_	_	_	_
26-14	4258-4264	stable	_	_	_	_
26-15	4265-4275	throughout	_	_	_	_
26-16	4276-4279	the	time[212]	giv[212]	coref	26-33[0_212]
26-17	4280-4289	treatment	event|time[212]	new|giv[212]	_	_
26-18	4290-4296	period	time[212]	giv[212]	_	_
26-19	4297-4298	,	_	_	_	_
26-20	4299-4306	despite	_	_	_	_
26-21	4307-4313	having	_	_	_	_
26-22	4314-4315	a	abstract[213]	giv[213]	coref	26-34[0_213]
26-23	4316-4321	worse	abstract[213]	giv[213]	_	_
26-24	4322-4332	functional	abstract[213]	giv[213]	_	_
26-25	4333-4344	improvement	abstract[213]	giv[213]	_	_
26-26	4345-4346	,	_	_	_	_
26-27	4347-4350	and	_	_	_	_
26-28	4351-4355	less	abstract[214]	giv[214]	_	_
26-29	4356-4365	magnitude	abstract[214]	giv[214]	_	_
26-30	4366-4368	of	abstract[214]	giv[214]	_	_
26-31	4369-4376	quality	abstract[214]|abstract[215]	giv[214]|new[215]	_	_
26-32	4377-4379	of	abstract[214]|abstract[215]	giv[214]|new[215]	_	_
26-33	4380-4384	life	abstract[214]|abstract[215]|abstract	giv[214]|new[215]|giv	coref	27-13
26-34	4385-4396	improvement	abstract[214]|abstract[215]|abstract	giv[214]|new[215]|giv	_	_
26-35	4397-4404	overall	abstract[214]|abstract[215]	giv[214]|new[215]	_	_
26-36	4405-4406	.	_	_	_	_

#Text=This study is the first to report this difference in quality of life measures between younger and older aged cohorts and has potentially large implications on pre-surgical assessment and counselling in older patients with DCM .
27-1	4407-4411	This	abstract[218]	giv[218]	coref	30-26[256_218]
27-2	4412-4417	study	abstract[218]	giv[218]	_	_
27-3	4418-4420	is	_	_	_	_
27-4	4421-4424	the	_	_	_	_
27-5	4425-4430	first	_	_	_	_
27-6	4431-4433	to	_	_	_	_
27-7	4434-4440	report	_	_	_	_
27-8	4441-4445	this	abstract[219]	new[219]	_	_
27-9	4446-4456	difference	abstract[219]	new[219]	_	_
27-10	4457-4459	in	abstract[219]	new[219]	_	_
27-11	4460-4467	quality	abstract[219]|abstract[220]	new[219]|new[220]	_	_
27-12	4468-4470	of	abstract[219]|abstract[220]	new[219]|new[220]	_	_
27-13	4471-4475	life	abstract[219]|abstract[220]|abstract|abstract[222]	new[219]|new[220]|giv|new[222]	coref|coref|coref|coref	28-37|30-10[252_222]|28-37|30-10[252_222]
27-14	4476-4484	measures	abstract[219]|abstract[220]|abstract[222]	new[219]|new[220]|new[222]	_	_
27-15	4485-4492	between	abstract[219]|abstract[220]|abstract[222]	new[219]|new[220]|new[222]	_	_
27-16	4493-4500	younger	abstract[219]|abstract[220]|abstract[222]|person[223]	new[219]|new[220]|new[222]|new[223]	_	_
27-17	4501-4504	and	abstract[219]|abstract[220]|abstract[222]|person[223]	new[219]|new[220]|new[222]|new[223]	_	_
27-18	4505-4510	older	abstract[219]|abstract[220]|abstract[222]|person[223]	new[219]|new[220]|new[222]|new[223]	_	_
27-19	4511-4515	aged	abstract[219]|abstract[220]|abstract[222]|person[223]	new[219]|new[220]|new[222]|new[223]	_	_
27-20	4516-4523	cohorts	abstract[219]|abstract[220]|abstract[222]|person[223]	new[219]|new[220]|new[222]|new[223]	_	_
27-21	4524-4527	and	_	_	_	_
27-22	4528-4531	has	_	_	_	_
27-23	4532-4543	potentially	abstract[224]	new[224]	_	_
27-24	4544-4549	large	abstract[224]	new[224]	_	_
27-25	4550-4562	implications	abstract[224]	new[224]	_	_
27-26	4563-4565	on	abstract[224]	new[224]	_	_
27-27	4566-4578	pre-surgical	abstract[224]|abstract[225]	new[224]|giv[225]	coref	30-11[0_225]
27-28	4579-4589	assessment	abstract[224]|abstract[225]	new[224]|giv[225]	_	_
27-29	4590-4593	and	_	_	_	_
27-30	4594-4605	counselling	_	_	_	_
27-31	4606-4608	in	_	_	_	_
27-32	4609-4614	older	person[226]	giv[226]	_	_
27-33	4615-4623	patients	person[226]	giv[226]	_	_
27-34	4624-4628	with	person[226]	giv[226]	_	_
27-35	4629-4632	DCM	person[226]|abstract	giv[226]|giv	coref	30-14[253_0]
27-36	4633-4634	.	_	_	_	_

#Text=However , age-related effects on health perception have been found to influence the SF-36 score , and the contribution from the perception of physical effects often misses a number of important determinants of overall quality of life in older persons .
28-1	4635-4642	However	_	_	_	_
28-2	4643-4644	,	_	_	_	_
28-3	4645-4656	age-related	abstract[228]	giv[228]	coref	28-24[235_228]
28-4	4657-4664	effects	abstract[228]	giv[228]	_	_
28-5	4665-4667	on	abstract[228]	giv[228]	_	_
28-6	4668-4674	health	abstract[228]|abstract|abstract[230]	giv[228]|new|giv[230]	_	_
28-7	4675-4685	perception	abstract[228]|abstract[230]	giv[228]|giv[230]	_	_
28-8	4686-4690	have	_	_	_	_
28-9	4691-4695	been	_	_	_	_
28-10	4696-4701	found	_	_	_	_
28-11	4702-4704	to	_	_	_	_
28-12	4705-4714	influence	_	_	_	_
28-13	4715-4718	the	abstract[232]	new[232]	_	_
28-14	4719-4724	SF-36	abstract|abstract[232]	giv|new[232]	_	_
28-15	4725-4730	score	abstract[232]	new[232]	_	_
28-16	4731-4732	,	_	_	_	_
28-17	4733-4736	and	_	_	_	_
28-18	4737-4740	the	abstract[233]	new[233]	_	_
28-19	4741-4753	contribution	abstract[233]	new[233]	_	_
28-20	4754-4758	from	abstract[233]	new[233]	_	_
28-21	4759-4762	the	abstract[233]|abstract[234]	new[233]|new[234]	_	_
28-22	4763-4773	perception	abstract[233]|abstract[234]	new[233]|new[234]	_	_
28-23	4774-4776	of	abstract[233]|abstract[234]	new[233]|new[234]	_	_
28-24	4777-4785	physical	abstract[233]|abstract[234]|abstract[235]	new[233]|new[234]|giv[235]	_	_
28-25	4786-4793	effects	abstract[233]|abstract[234]|abstract[235]	new[233]|new[234]|giv[235]	_	_
28-26	4794-4799	often	_	_	_	_
28-27	4800-4806	misses	_	_	_	_
28-28	4807-4808	a	abstract[236]	new[236]	coref	29-15[245_236]
28-29	4809-4815	number	abstract[236]	new[236]	_	_
28-30	4816-4818	of	abstract[236]	new[236]	_	_
28-31	4819-4828	important	abstract[236]	new[236]	_	_
28-32	4829-4841	determinants	abstract[236]	new[236]	_	_
28-33	4842-4844	of	abstract[236]	new[236]	_	_
28-34	4845-4852	overall	abstract[236]|abstract[237]	new[236]|new[237]	ana	29-5[0_237]
28-35	4853-4860	quality	abstract[236]|abstract[237]	new[236]|new[237]	_	_
28-36	4861-4863	of	abstract[236]|abstract[237]	new[236]|new[237]	_	_
28-37	4864-4868	life	abstract[236]|abstract[237]|abstract	new[236]|new[237]|giv	coref	29-15
28-38	4869-4871	in	abstract[236]|abstract[237]	new[236]|new[237]	_	_
28-39	4872-4877	older	abstract[236]|abstract[237]|person[239]	new[236]|new[237]|new[239]	_	_
28-40	4878-4885	persons	abstract[236]|abstract[237]|person[239]	new[236]|new[237]|new[239]	_	_
28-41	4886-4887	.	_	_	_	_

#Text=For these reasons , it has been suggested that the focus of quality of life determinants in the elderly should be weighted toward mental components rather than the physical .
29-1	4888-4891	For	_	_	_	_
29-2	4892-4897	these	abstract[240]	new[240]	_	_
29-3	4898-4905	reasons	abstract[240]	new[240]	_	_
29-4	4906-4907	,	_	_	_	_
29-5	4908-4910	it	abstract	giv	coref	29-13
29-6	4911-4914	has	_	_	_	_
29-7	4915-4919	been	_	_	_	_
29-8	4920-4929	suggested	_	_	_	_
29-9	4930-4934	that	_	_	_	_
29-10	4935-4938	the	abstract[242]	new[242]	_	_
29-11	4939-4944	focus	abstract[242]	new[242]	_	_
29-12	4945-4947	of	abstract[242]	new[242]	_	_
29-13	4948-4955	quality	abstract[242]|abstract	new[242]|giv	_	_
29-14	4956-4958	of	abstract[242]	new[242]	_	_
29-15	4959-4963	life	abstract[242]|abstract|abstract[245]	new[242]|giv|giv[245]	_	_
29-16	4964-4976	determinants	abstract[242]|abstract[245]	new[242]|giv[245]	_	_
29-17	4977-4979	in	abstract[242]|abstract[245]	new[242]|giv[245]	_	_
29-18	4980-4983	the	abstract[242]|abstract[245]	new[242]|giv[245]	_	_
29-19	4984-4991	elderly	abstract[242]|abstract[245]	new[242]|giv[245]	_	_
29-20	4992-4998	should	_	_	_	_
29-21	4999-5001	be	_	_	_	_
29-22	5002-5010	weighted	_	_	_	_
29-23	5011-5017	toward	_	_	_	_
29-24	5018-5024	mental	abstract[246]	new[246]	_	_
29-25	5025-5035	components	abstract[246]	new[246]	_	_
29-26	5036-5042	rather	_	_	_	_
29-27	5043-5047	than	_	_	_	_
29-28	5048-5051	the	abstract[247]	new[247]	ana	30-1[0_247]
29-29	5052-5060	physical	abstract[247]	new[247]	_	_
29-30	5061-5062	.	_	_	_	_

#Text=This also raises certain questions about the efficacy of functional assessment measures for DCM in the elderly , but this was beyond the scope of the current study .
30-1	5063-5067	This	abstract	giv	ana	30-20
30-2	5068-5072	also	_	_	_	_
30-3	5073-5079	raises	_	_	_	_
30-4	5080-5087	certain	abstract[249]	new[249]	_	_
30-5	5088-5097	questions	abstract[249]	new[249]	_	_
30-6	5098-5103	about	abstract[249]	new[249]	_	_
30-7	5104-5107	the	abstract[249]|abstract[250]	new[249]|new[250]	_	_
30-8	5108-5116	efficacy	abstract[249]|abstract[250]	new[249]|new[250]	_	_
30-9	5117-5119	of	abstract[249]|abstract[250]	new[249]|new[250]	_	_
30-10	5120-5130	functional	abstract[249]|abstract[250]|abstract[252]	new[249]|new[250]|giv[252]	_	_
30-11	5131-5141	assessment	abstract[249]|abstract[250]|abstract|abstract[252]	new[249]|new[250]|giv|giv[252]	_	_
30-12	5142-5150	measures	abstract[249]|abstract[250]|abstract[252]	new[249]|new[250]|giv[252]	_	_
30-13	5151-5154	for	abstract[249]|abstract[250]|abstract[252]	new[249]|new[250]|giv[252]	_	_
30-14	5155-5158	DCM	abstract[249]|abstract[250]|abstract[252]|abstract[253]	new[249]|new[250]|giv[252]|giv[253]	_	_
30-15	5159-5161	in	abstract[249]|abstract[250]|abstract[252]|abstract[253]	new[249]|new[250]|giv[252]|giv[253]	_	_
30-16	5162-5165	the	abstract[249]|abstract[250]|abstract[252]|abstract[253]	new[249]|new[250]|giv[252]|giv[253]	_	_
30-17	5166-5173	elderly	abstract[249]|abstract[250]|abstract[252]|abstract[253]	new[249]|new[250]|giv[252]|giv[253]	_	_
30-18	5174-5175	,	_	_	_	_
30-19	5176-5179	but	_	_	_	_
30-20	5180-5184	this	abstract	giv	_	_
30-21	5185-5188	was	_	_	_	_
30-22	5189-5195	beyond	_	_	_	_
30-23	5196-5199	the	abstract[255]	new[255]	_	_
30-24	5200-5205	scope	abstract[255]	new[255]	_	_
30-25	5206-5208	of	abstract[255]	new[255]	_	_
30-26	5209-5212	the	abstract[255]|abstract[256]	new[255]|giv[256]	_	_
30-27	5213-5220	current	abstract[255]|abstract[256]	new[255]|giv[256]	_	_
30-28	5221-5226	study	abstract[255]|abstract[256]	new[255]|giv[256]	_	_
30-29	5227-5228	.	_	_	_	_
